title: [Hepatitis B: who should be treated?].
abstract: Patients with moderate to severe chronic hepatitis and active HBV replication should be managed according to HBeAg status and presence of coinfecting virus(es) (HDV, HCV, HIV). Treatment is also recommended for immunocompromised patients and those older than 60 years with acute HBV infection. Current treatment of chronic hepatitis B has limited long-term efficacy. The patient's age, severity of liver disease, likelihood of response and possibility of adverse effects and complications should be considered before deciding on treatment.
authors.affiliation: Klinika za infektivne bolesti i febrilna stanja, Klinicki bolnicki centar Rijeka, Rijeka, Hrvatska. ivica.pavic@ri.htnet.hr
authors.forename: Ivica
authors.initials: I
authors.lastname: Pavić
mesh_terms: D000208:Acute Disease; D015658:HIV Infections / Q000150:complications; D006526:Hepatitis C / Q000150:complications / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D019698:Hepatitis C, Chronic / Q000188:drug therapy / Q000276:immunology / Q000821:virology; D003699:Hepatitis D / Q000150:complications; D006801:Humans; D008103:Liver Cirrhosis / Q000821:virology